This compound is produced in the kidneys and liver from the amino acids - methionine and lysine
doi: 10.1139/cjpp-2017-0683 Summary Keywords GLP-1, Alzheimers disease, blood pressure, DPP-4, non-alcoholic steatohepatitis, signaling pathway Citation Li Q-X, Gao H, Guo Y-X, Wang B-Y, Hua R, Gao L, Shang H-W, Lu X and Xu J-D (2021) GLP-1 and Underlying Beneficial Actions in Alzheimers Disease, Hypertension, and NASH
It is worth mentioning that in the AWARD-2 study, there were several cases of pancreatitis caused by DUL (112)
I meet with her once a month for rechecks and have lost weight safely each month with no real side effects
Abstract 1046-P Marathe CS, Rayner CK, Jones KL, Horowitz M (2013) Relationships between gastric emptying, postprandial glycemia, and incretin hormones
A GLP-1 maintenance dose may involve: Staying at a mid-range dose Reducing to a lower dose Avoiding escalation once weight is stable There is no requirement to reach the maximum licensed dose to remain on treatment